Calciphylaxis: Treatment and outlook-CME part II

doi:10.1016/j.jaad.2021.10.063

Calciphylaxis: Treatment and outlook-CME part II

2022-05-01

10

PRE

AI

Alex G. Ortega‐Loayza *

DOI：10.1016/j.jaad.2021.10.063

Original

Original request for help

Save

Abstract

En 中文

Calciphylaxis is a rare and devastating condition with important systemic ramifications. This second-part of our CME aims to educate the practicing dermatologist on the current standard of care once a diagnosis of calciphylaxis is confirmed or highly suspected. The key pathologic findings, as well as the role and limitations of biopsy, are reviewed. We aim to guide readers through the complex hospitalization and posthospitalization management of these medically vulnerable patients. Collaboration with other specialists will be discussed. Experimental and developing treatments are discussed, and the outlook of the condition is reported.

Keywords:

calciphylaxis

calcium

clinical trials

ESRD

palliative care

sodium thiosulfate

Calciphylaxis: Treatment and outlook-CME part II

Abstract

Journal

Organization